GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The IBN SINA Pharmaceutical Industry PLC (DHA:IBNSINA) » Definitions » NonCurrent Deferred Liabilities

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) NonCurrent Deferred Liabilities : BDT0.00 Mil (As of . 20)


View and export this data going back to . Start your Free Trial

What is The IBN SINA Pharmaceutical Industry NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

The IBN SINA Pharmaceutical Industry's non-current deferred liabilities for the quarter that ended in . 20 was BDT0.00 Mil.

The IBN SINA Pharmaceutical Industry NonCurrent Deferred Liabilities Historical Data

The historical data trend for The IBN SINA Pharmaceutical Industry's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The IBN SINA Pharmaceutical Industry NonCurrent Deferred Liabilities Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
NonCurrent Deferred Liabilities

The IBN SINA Pharmaceutical Industry Semi-Annual Data
NonCurrent Deferred Liabilities

The IBN SINA Pharmaceutical Industry NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of The IBN SINA Pharmaceutical Industry's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


The IBN SINA Pharmaceutical Industry Business Description

Traded in Other Exchanges
N/A
Address
Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.

The IBN SINA Pharmaceutical Industry Headlines

No Headlines